Certain embodiments of the invention provide a method for identifying a cancer cell that is sensitive to a biguanide compound or other CYP epoxygenase inhibitor, comprising detecting increased expression of at least one cytochrome P450 (CYP) and/or decreased expression of soluble epoxide hydrolase (EPHX2) in the cancer cell, wherein increased CYP expression and/or decreased expression of EPHX2 in the cancer cell correlates with increased sensitivity of the cancer cell to the biguanide compound or other CYP epoxygenase inhibitor.
本发明的某些实施例提供了一种用于识别对双胍类化合物或其他CYP环氧化酶
抑制剂敏感的癌细胞的方法,包括检测癌细胞中至少一个细胞色素P450(CYP)的表达增加和/或可溶性
环氧化物水解酶(EPHX2)的表达减少,其中癌细胞中CYP表达增加和/或EPHX2表达减少与癌细胞对双胍类化合物或其他CYP环氧化酶
抑制剂的敏感性增加相关。